Fly Intel: Top five analyst downgrades

Catch up on today’s top five analyst downgrades with this list compiled by The Fly: 1. FibroGen (FGEN) downgraded to Neutral from Buy at H.C. Wainwright and Mizuho. 2. Casey’s General Stores (CASY) downgraded to Market Perform from Outperform at Raymond James with analyst Bobby Griffin saying the downgrade is not a reflection of Casey’s recent operating performance or management’s capabilities, but a factor of Casey’s valuation versus its historical valuation and peers. 3. Ameris Bancorp (ABCB) downgraded to Outperform from Strong Buy at Raymond James with analyst David Feaster saying the downgrade is driven by its strong performance since September 2020. 4. Bright Horizons (BFAM) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Toni Kaplan saying the potential for changing on-site work dynamics and more employer flexibility post-pandemic could result in daycare becoming more local to employee homes and lead to increased competition for Bright Horizons. 5. Sempra Energy (SRE) downgraded to Neutral from Buy at Seaport Global with analyst Angie Storozynski saying the KKR (KKR) deal should make the IEnova stock tender more expensive, noting that market valuations of California utility peers are “sharply discounted.” This list is just a portion of The Fly’s full analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire